Currently, the drugs targeting NF-κB and oxidative stress for the treatment of AP include curcumin 14, 16, visnagin 17, shikonin 18, and lycopene 19, which are plant extracts that can reduce the level of oxidative stress and inhibit the activation of NF-κB. Here, NFKB1 is linked to alkaline phosphatase measurement.